Society Letters

Endocrine Society Comments on FDA Office of Women's Health Strategic Plan

September 02, 2020

To: Lowell Schiller and Dr. Kaveeta Vasisht

"The Endocrine Society appreciates the opportunity to comment on the strategic priorities of the Food and Drug Administration’s Office of Women’s Health (OWH). Founded in 1916, the Endocrine Society is the world’s oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. The Society’s membership of over 18,000 includes experts in all research and clinical aspects of hormone health, including women’s health and reproductive health.
We offer the recommendations below, which highlight areas of particular relevance to endocrine research and clinical practice. These recommendations are also shared by the Society for Women’s Health Research."

arrowRead the Full Comment Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!